d-AMPHETAMINE AS A PREDICTOR FOR RESPONSE TO IMIPRAMINE AND AMITRIPTYLINE

Area of Science:

• Clinical Psychiatry
• Pharmacology
• Neuroscience

Background:

• Endogenous depression is a significant psychiatric condition requiring effective treatment.
• Assessing treatment response in depression is crucial for patient outcomes.
• D-amphetamine and tricyclic antidepressants are established treatments for depression.

Purpose of the Study:

• To investigate the relationship between treatment response to d-amphetamine and tricyclic antidepressants in patients with endogenous depression.
• To determine if improvement with d-amphetamine predicts response to tricyclic therapy.

Main Methods:

• A clinical trial involving patients diagnosed with endogenous depression based on Feighner's criteria.
• Patients had baseline scores above 20 on Hamilton's depression rating scale.
• Participants were assigned to groups receiving placebo, d-amphetamine, or tricyclic antidepressants.

Main Results:

• All patients who showed improvement with d-amphetamine also demonstrated improvement when treated with tricyclic antidepressants.
• Two patients who did not respond to d-amphetamine also did not respond to tricyclic antidepressants.
• This suggests a correlation in treatment efficacy between the two drug classes.

Conclusions:

• Treatment response to d-amphetamine may indicate a similar response to tricyclic antidepressants in endogenous depression.
• These findings could inform treatment selection for patients with endogenous depression.
• Further research is warranted to explore the shared mechanisms of action.